Synthesis and Antiproliferative Activity Evaluation of Aryl(Hetaryl)Cyclopentenone Analogs of Combretastatin A-4
- Autores: Shirinyan V.Z.1, Markosyan A.I.2, Baryshnikova M.A.3, Yaminova L.V.4, L’vov A.G.1, Gabrielyan S.A.2
- 
							Afiliações: 
							- N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences
- Scientific and Technological Center of Organic and Pharmaceutical Chemistry, National Academy of Sciences of Armenia
- N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
- D. I. Mendeleev University of Chemical Technology of Russia
 
- Edição: Volume 51, Nº 10 (2018)
- Páginas: 867-872
- Seção: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244834
- DOI: https://doi.org/10.1007/s11094-018-1706-8
- ID: 244834
Citar
Resumo
A series of previously unreported di- and triaryl(hetaryl)cyclopentenone derivatives were prepared using a convenient synthetic method and screened preliminarily for antitumor activity in four human cell lines, i.e., T-cell leukemia (Jurkat), lung adenocarcinoma (A-549), colon cancer (HCT-116), and breast adenocarcinoma (MCF-7). The most cytotoxic of the tested compounds was 2-(3,4,5-trimethoxyphenyl)-3-(4-methoxyphenyl) cyclopent-2-en-1-one. However, it was inactive against lymphocytic leukemia P388 in mice despite its cytotoxicity in in vitro tests.
Palavras-chave
Sobre autores
V. Shirinyan
N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences
							Autor responsável pela correspondência
							Email: shir@ioc.ac.ru
				                					                																			                												                	Rússia, 							47 Leninskii Prosp, Moscow, 119991						
A. Markosyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry, National Academy of Sciences of Armenia
														Email: shir@ioc.ac.ru
				                					                																			                												                	Armênia, 							26 Azatutyan Pr., 0014, Yerevan, 375014						
M. Baryshnikova
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
														Email: shir@ioc.ac.ru
				                					                																			                												                	Rússia, 							23 Kashirskoe Shosse, Moscow, 115478						
L. Yaminova
D. I. Mendeleev University of Chemical Technology of Russia
														Email: shir@ioc.ac.ru
				                					                																			                												                	Rússia, 							9 Miusskaya Pl., Moscow, 125047						
A. L’vov
N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences
														Email: shir@ioc.ac.ru
				                					                																			                												                	Rússia, 							47 Leninskii Prosp, Moscow, 119991						
S. Gabrielyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry, National Academy of Sciences of Armenia
														Email: shir@ioc.ac.ru
				                					                																			                												                	Armênia, 							26 Azatutyan Pr., 0014, Yerevan, 375014						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					